MALDI-TOF MS-based drug susceptibility testing of pathogens: The example of Candida albicans and fluconazole.


Autoria(s): Marinach C.; Alanio A.; Palous M.; Kwasek S.; Fekkar A.; Brossas J.Y.; Brun S.; Snounou G.; Hennequin C.; Sanglard D.; Datry A.; Golmard J.L.; Mazier D.
Data(s)

2009

Resumo

MALDI-TOF MS can be used for the identification of microorganism species. We have extended its application to a novel assay of Candida albicans susceptibility to fluconazole, based on monitoring modifications of the proteome of yeast cells grown in the presence of varying drug concentrations. The method was accurate, and reliable, and showed full agreement with the Clinical Laboratory Standards Institute's reference method. This proof-of-concept demonstration highlights the potential for this approach to test other pathogens.

Identificador

http://serval.unil.ch/?id=serval:BIB_903E0C449ED3

isbn:1615-9861[electronic]

pmid:19750514

doi:10.1002/pmic.200900152

isiid:000271554100006

Idioma(s)

en

Fonte

Proteomics, vol. 9, no. 20, pp. 4627-4631

Palavras-Chave #Algorithm; Candida albicans; MALDI-TOF MS; Microbiology; Proteome profiling; Target for drugs; Mass-Spectrometry; Interpretive Breakpoints; European Committee; National Committee; Clsi M27-A2; Identification; Itraconazole; Infections; Spp.
Tipo

info:eu-repo/semantics/article

article